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AbsTrACT
Social position is known to play a role in the quality of 
ageing, notably through the stimulation/dysregulation 
of key physiological systems in response to external 
stresses. Using data from one wave of Understanding 
Society including 9088 participants, we defined, as an 
extension of the allostatic load, a synthetic Biological 
Health Score (BHS) capturing the wear-and-tear of 
four physiological systems (endocrine, inflammatory, 
cardiovascular and metabolic systems) and two organs 
(liver and kidney). We used 16 established blood-derived 
biomarkers of these systems to calculate the BHS and 
explored the relative contribution of socioeconomic 
position to the BHS and its main components across age 
groups. We identified a systematic decreasing education-
related gradient of the BHS (p<0.001) leading to lower 
biological risk in participants with longer education. 
Education-related differences in the BHS were detected 
early in life, and were not attributable to lifestyle and 
behavioural factors. We found a consistent contribution 
of the inflammatory and metabolic systems to the overall 
score throughout from early adulthood onwards, while 
the contribution of the other four systems seems to vary 
across age groups and gender. Our findings highlight 
the social-to-biological processes ultimately leading to 
health inequalities, and suggest that such disparities can 
already be detected in the 20–40 years old age group 
and cannot be fully explained by lifestyle and behavioural 
factors. This may define early adulthood social condition 
as a precursor to accelerated biological ageing and as an 
important target for public health policies.
InTroduCTIon
The basic requirements for human life rely on the 
adequate function of biological systems, allowing 
for cognitive and physical performance, and overall 
well-being. There is increasing evidence that 
physiological functioning is socially patterned,1–3 
suggesting that living in disadvantaged social condi-
tions leads to physiological adaptation that may 
have a cost in terms of physiological dysregulation 
developing over time. This is likely to contribute 
to unhealthy ageing, notably through subsequent 
inflation of the individual risk of chronic diseases.
Questions around how environmental factors 
lead to biological alterations over time can now be 
investigated on a wider scale, and in a variety of 
contexts and disciplines.4 One of the main issues 
is how to measure socioeconomic-related physi-
ological changes at different life stages, that is, in 
relation to biological wear-and-tear, or to biolog-
ical ageing, rather than in relation to specific 
pathologies. The relationships between molecular 
markers, physiological systems and overall physical 
and cognitive performances are under increased 
scrutiny by researchers attempting to elucidate 
the mechanisms involved in predisease and even 
‘normal’ physiological contexts.5–7 In this frame-
work, ageing is modelled as a progressive decline 
of the integrity and/or level of functioning across 
multiple organ systems.5 Due to the complexity of 
the ageing process and to the pleiotropic contribu-
tion of several systems to the quality of ageing, the 
use of multisystem scores has been proposed and 
appears to provide an efficient and interpretable 
alternative to the investigation of (sets of) priori-
tised biomarkers.8
The allostatic load (AL) as originally defined is a 
composite score measuring the lifelong physiolog-
ical wear-and-tear mainly related to stress response. 
Developments beyond the concept of AL9 have 
demonstrated that socioeconomic adversity, partic-
ularly in early life, leads to a higher load (ie, higher 
lifelong stimulation of several key physiological 
systems), which has been related to increased risk 
of health outcomes such as mortality, morbidity and 
unhealthy ageing.10–12
Building on the concept of the AL, we hypothe-
sise here that socioeconomic differences in biolog-
ical health occur throughout the age range of the 
population, hence suggesting that socially stratified 
physiological differences could be detected from 
early life and could persist over the life course, 
and could therefore help in better understanding 
the ageing processes.13 Using data from Under-
standing Society, we adopt the same methodology 
as that developed for the AL and include liver and 
kidney functions which were available in the study 
and represent non-primarily stress-related systems 
involved in human physiological wear-and-tear.8 14 
We use our extended definition of the AL and first 
explore the evolution of the score across age 
groups. We subsequently assess if there is a system-
atic Biological Health Score (BHS) gradient related 
to education, and quantify, among the six systems 
considered in our score, those mostly contrib-
uting to the BHS and to its age and education-re-
lated variation. Finally, we investigate whether 
Slom
an Library. Protected by copyright.
 o
n
 N
ovem
ber 28, 2019 at Periodicals Section Albert
http://jech.bmj.com/
J Epidem
iol Com
m
unity Health: first published as 10.1136/jech-2018-212010 on 3 April 2019. Downloaded from 
2 Karimi M, et al. J Epidemiol Community Health 2019;0:1–10. doi:10.1136/jech-2018-212010
research report
box 1 definition and calculation of the biological Health 
score (bHs) (A) and system-specific scores (b)
A. Definition of the BHS.
 ► The BHS is calculated using the distribution of the (n=16) 
biomarkers included in the study and targeting four 
physiological systems (as included in the allostatic load) and 
two organs:
1. Endocrine system (n=1/2 biomarkers in women and men, 
respectively): dehydroepiandrosterone sulfate (DHEA-S) and 
testosterone (in men only).
2. Metabolic system (n=4): glycated haemoglobin, high-
density lipoprotein cholesterol (HDL), total cholesterol and 
triglycerides.
3. Cardiovascular system (n=3): systolic and diastolic blood 
pressure, and pulses.
4. Inflammatory/Immune system (n=3): C reactive protein, 
fibrinogen and insulin-like growth factor 1 (IGF-1).
5. Liver function (n=3): alanine transaminase, aspartate 
transaminase and gamma glutamyltransferase.
6. Kidney function (n=1): creatinine.
 ► For a given individual  i , the BHS is calculated as the sum 
(across all 16 biomarkers) of binary variables indicating 
if that person belongs to the ‘at-risk’ quartiles of each 
biomarkers. 
BHSi =
16∑
k=1
Iik, where
krepresents the biomarker, and Iik the binary variable 
informing if levels of biomarker k measured in individual i are in 
the at-risk quartile.
 ► The ‘at-risk’ quartile is defined as the lowest quartile for 
DHEA-S, testosterone, HDL and IGF-1, and the highest 
quartile for all remaining 12 biomarkers.
 ► Quartiles are calculated for both genders and each age group 
separately.
 ► The BHS measures the cumulated biological risk (across 
systems and/or biomarkers) a participant of a given age and 
gender is subjected to.
B. Definition of the system-specific subscores.
 ► To investigate the relative contribution of each system 
system-specific subscores are calculated as the sum of the 
same binary variables, but restricted to the system they 
measure. To ensure comparability across system-specific 
subscores, these are standardised by the number of 
biomarkers measuring that system. Specifically, for individual 
 i :BHSis =
ns∑
k=1
Iik
ns , where
BHSisis the system-specific subscore for system s, and ns is 
the number of biomarkers in system s.
observed BHS differentials are driven by established lifestyle 
and behavioural factors.
MATerIAls And MeTHods
study population
Beginning in 2009–2010, Understanding Society, or the UK 
Household Longitudinal Study, is an annual longitudinal survey 
of more than 40 000 UK households. It consists of a general 
population sample (GPS), a stratified clustered random sample 
of households representative of the UK population, as well as 
a smaller component from the pre-existing British Household 
Panel Survey. Annual interviews collecting sociodemographic 
information are conducted throughout each year. In this study 
we used a subset of the GPS sample who participated in a single 
nurse visit when physical measures and blood samples were 
collected. This took place in the participant’s home 5 months 
after the annual wave 2 interview in 2010–2012. Respondents 
were eligible for a nurse visit if they had taken part in that wave’s 
main interview in English; were aged 16+; lived in England, 
Wales or Scotland; and were not pregnant. Of 35 875 partici-
pants meeting these requirements, 15 591 adults took part in 
wave 2 of the nurse health assessment, and blood samples were 
collected from 10 175 participants.15
socioeconomic position
Educational level captures the length of formal education and 
characterises the qualification, and can therefore be viewed as an 
indicator of socioeconomic position that jointly relates to social 
class, social status and material circumstances. In the present 
study we used participants’ or their parent’s educational level 
as a six-level categorical variable. We regrouped these levels 
into three groups: low (no qualification), intermediate (GSCE 
(General Certificate of secondary Education) and so on, other 
qualification, A level and so on) and high (degree and higher 
degree) for individual education. For parental educational level 
the new groups were low education (did not go to school at all, 
left school with no qualifications or certificates), intermediate 
(left school with some qualifications or certificates, other) and 
high (gained post school qualifications or certificates, a univer-
sity degree or higher degree). As a measure of Socio Economic 
Position (SEP), individuals aged younger than 25 years were 
attributed the highest achieved parental or individual educa-
tional level, and participants aged 25 or older are attributed their 
own educational level.
biomarkers
Based on a systems approach reconciling the literature on AL, 
biological ageing and the human disease network,15–18 we selected 
a panel of 15 (women) or 16 (men) biomarkers measured in the 
blood samples collected at the nurse health assessment. These 
related to four systems: endocrine, cardiovascular, metabolic 
and inflammatory; and to the function of two organs: liver and 
kidney (see box 1).
definition of the bHs
We defined biological risk by using the sample distribution 
of each biomarker based on the method used for calculating 
the AL,19 stratified by age group and gender (see box 1). We 
included in the BHS all systems originally included in the AL, 
and additionally included kidney and liver functions. An indi-
vidual is considered to be ‘at risk’ for a given biomarker if his/her 
measured value of that biomarker is in the extreme quartile of 
the empirical distribution of that biomarker in the age group and 
gender the individual belongs to. If an individual is defined as 
being ‘at risk’ for a biomarker, he/she is attributed a subscore of 
1 for that particular biomarker and 0 otherwise. The individual 
BHS is derived by summing biomarker-specific scores across all 
biomarkers. The overall BHS then reflects the level of biological 
risk per age group and gender (see box 1-A).
In order to quantitatively compare the contribution of each 
system to the overall score, we also calculated a per-system score 
by summing biomarker-specific scores across all biomarkers 
within each system, and scaled the system-specific subscore by 
the number of biomarkers involved in each system (see box 1-B).
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Covariates
Marital status is a categorical variable in four groups: single, 
living as couple or married, separated or divorce, and widowed. 
Overcrowding was defined as the number people per room in 
the household (categorical, binary: <1.5 person per room or 
≥1.5 person per room).20 Comorbidities originally included 17 
diseases and were categorised here into three groups: none, one, 
and two or more comorbidities. Medicines and treatments were 
originally coded as binary variables describing if the participant 
reported the use of a treatment for 10 different types of patholo-
gies, and were recoded into none, one, and two or more reported 
treatments. Smoking, physical activity and alcohol consumption 
were used as originally coded in the study. For smoking, a binary 
variable was used indicating if the participant had ever smoked. 
Physical activity was a binary variable indicating if the partic-
ipant practised one or more sports. Alcohol consumption was 
grouped into four categories (non-drinker, less than two times 
in the last year; social drinker, once or twice a month; moderate 
drinker, once or twice a week; and daily drinker, 3 days a week 
or more). Body mass index (BMI, kg/m2) was defined using the 
WHO five groups: <18.5, (18.5, 25), (25, 30), (30, 40) and  ≥
 40.
statistical analysis
Age grouping was defined to ensure that all age groups included 
a sufficient and comparable (online supplementary table 1) 
number of participants, and four categories were considered: 
20–40, 41–52, 53–64 and 65–79 years old. Individuals with all 
missing biomarkers were excluded from the analyses. If the value 
of a given biomarker was missing, a null subscore was allocated 
to the individual for that specific biomarker.
In order (1) to capture the reported differential social health 
gradients in men and women and (2) to investigate age ranges at 
which these could be detected, we first investigated the values 
of the BHS (and of each system-specific subscores) by age group 
and gender, and education group separately. Specifically, we 
calculated the mean BHS for each age group  a , gender  g , and 
obtained three estimated mean BHS values:  BHSa,g,L ,  BHSa,g,I  
and  BHSa,g,H , for low, intermediate and high SEP groups, respec-
tively. These three values were compared in each age and gender 
category using a Student’s t-test and using the value in the high 
SEP group ( BHSa,g,H ) as a reference. We also tested if these three 
values for each age group and gender were supportive of a trend 
across SEP groups using a non-parametric Kruskal-Wallis rank 
test. These analyses were also performed on each system-specific 
subscore.
In order to evaluate the effect of SEP on the changes in mean 
BHS, taking into account possible confounders, we used the 
following model, for each age group and gender separately (ie, 
pooling data across SEP groups):
 BHSi,a,g = α+ βSEPia,g × SEPi + βFEia,g × FEi + εi, where 
 FEi combines the observed values of the set of potential 
confounders for individual  i , and  SEPi  is the SEP category indi-
vidual  i belongs to. In that setting,  βLowa,g   and  βIntermediatea,g  , the 
estimates of the adjusted effect of SEP on the BHS for the low 
and intermediate SEP categories, respectively, can be interpreted 
as the average difference in BHS in the low and intermediate SEP 
groups compared with what is observed in the high SEP group, 
independently of the adjustment variables.
In a benchmark model (model 1), we did not include any 
adjustment variable in FE , and sequentially adjusted the model 
for the following covariates:
 ► Model 2=model 1 + marital status and overcrowding.
 ► Model 3=model 2 + comorbidities.
 ► Model 4=model 3 + medicines and treatments.
 ► Model 5=model 4 + smoking, physical activity and alcohol 
consumption.
 ► Model 6=model 5 + BMI.
We considered throughout a nominal significance level of 
0.05. Statistical analyses were performed using R V.3.4.0 in the 
RStudio environment.
resulTs
study population and bHs distribution
Of the original 10 175 eligible participants, 281 did not have 
full information from their interview and/or nurse health assess-
ment. Of the remaining 9894 participants, 10 were excluded as 
not being in year 2 of primary sampling unit. We also restricted 
the age range of our study population and excluded (n=311) 
participants aged younger than 20 and (n=457) older than 
79. Of the remaining 9116 participants, we excluded 1 due to 
outlying biomarkers measurement (in the last quartiles for 15 
of 16 biomarkers), 20 due to all 15 of 16 biomarkers missing, 
6 due to missing information on education and 1 due to aber-
rant BMI value. This resulted in a total of 9088 (3992 men and 
5096 women) participants being included in our study, and their 
main characteristics are presented in online supplementary table 
1. Of the (n=315) participants aged 20–24, 163 were allocated 
parental educational level and 152 their own. Younger age 
groups had a smaller proportion of individuals in the low educa-
tion group compared with the older age groups. As expected, the 
number of comorbidities and treatments is higher in older age 
groups in both men and women. The proportion of individuals 
who have ever smoked is almost the same in different age groups 
for women, but is higher for older men compared with young 
men. Online supplementary table 2 presents the summary statis-
tics and the percentage of missing values for each biomarker by 
age group and gender. A majority of participants included in the 
study did not have any missing biomarkers value (>64%); we 
excluded 20 participants with all 15 of 16 biomarkers missing, 
and only 295 (149 men and 146 women) had 4 or more missing 
(and subsequently imputed) biomarker measurements (online 
supplementary table 3).
The BHS distribution calculated across all age groups shows 
clear differences for each covariate (p<0.0001) except house-
hold overcrowding (p=0.444) (table 1). This indicates higher 
BHS values in men, in smokers, in participants who were sepa-
rated, divorced or widowed, and in participants with lower 
education, comorbidities and medical treatments, higher BMI, 
and low physical activity.
BHS values calculated for each age and educational group in 
men (figure 1A) and women (figure 1B) show differences across 
age groups (p<0.05). Irrespective of age and gender we found 
a clear and consistent social gradient in BHS leading to higher 
scores (ie, higher biological risk) in participants with lower 
education.
Similarly, in both genders we observed values of BHS in the 
intermediate SEP category which were higher (p<0.05) than 
those observed in the high education group, for all age groups, 
except for women aged 65–79 years.
Similar analyses were conducted on each system-specific score 
(table 2). In both genders and in all age groups, we found statis-
tically significant trends (p<0.001, not shown) for all systems. 
We found higher system-specific subscores in the low education 
group, for all systems except for kidney function. The compar-
ison of the mean system-specific scores within each age group 
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Table 1 Summary statistics for the Biological Health Score (BHS) calculated by age group
Age groups
 20–40 41–52 53–64 65–79 Total sample
 (n=2276) (n=2380) (n=2298) (n=2134) (n=9088)
 Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Gender 
  Male 3.914 (2.731) 4.016 (2.493) 4.033 (2.427) 3.955 (2.212) 3.981 (2.466)
  Female 3.707 (2.447) 3.735 (2.609) 3.697 (2.363) 3.828 (2.212) 3.738 (2.424)
  P value 0.237 0.002 0.001 0.202 <0.0001
Education 
  Low 4.988 (2.926) 4.517 (2.651) 4.527 (2.318) 4.184 (2.340) 4.386 (2.422)
  Intermediate 4.073 (2.639) 4.050 (2.504) 3.890 (2.405) 3.854 (2.147) 3.971 (2.438)
  High 3.482 (2.437) 3.503 (2.585) 3.464 (2.350) 3.642 (2.150) 3.510 (2.416)
  P value <0.0001 <0.0001 <0.0001 0.0005 <0.0001
Marital status 
  Single 3.455 (2.554) 3.936 (2.640) 3.979 (2.540) 3.602 (2.083) 3.638 (2.538)
  Living as couple or married 3.935 (2.558) 3.791 (2.534) 3.758 (2.371) 3.834 (2.213) 3.826 (2.429)
  Separated or divorced 3.775 (2.729) 4.154 (2.667) 4.089 (2.411) 4.284 (2.197) 4.126 (2.485)
  Widowed 2.750 (2.061) 3.250 (2.468) 4.308 (2.489) 3.955 (2.236) 3.994 (2.308)
  P value 0.0003 0.082 0.027 0.025 <0.0001
Household overcrowding 
  No 3.754 (2.553) 3.808 (2.569) 3.870 (2.388) 3.902 (2.223) 3.835 (2.436)
  Yes 3.947 (2.640) 4.148 (2.524) 3.564 (2.519) 3.716 (2.054) 3.916 (2.520)
  P value 0.190 0.010 0.055 0.460 0.444
Comorbidities 
  None 3.535 (2.444) 3.352 (2.382) 3.290 (2.237) 3.406 (2.107) 3.411 (2.346)
  One 4.072 (2.659) 4.198 (2.565) 3.804 (2.360) 3.730 (2.134) 3.938 (2.428)
  Two or more 5.318 (2.818) 5.032 (2.752) 4.550 (2.440) 4.259 (2.268) 4.564 (2.478)
  P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Number of treatments 
  None 3.539 (2.505) 3.449 (2.432) 3.326 (2.279) 3.489 (2.146) 3.460 (2.404)
  One 3.899 (2.520) 3.784 (2.438) 3.772 (2.271) 3.529 (2.017) 3.747 (2.321)
  Two or more 5.069 (2.685) 4.970 (2.721) 4.432 (2.482) 4.180 (2.278) 4.476 (2.482)
  P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Smoking 
  Never 3.613 (2.541) 3.623 (2.493) 3.733 (2.404) 3.711 (2.181) 3.666 (2.421)
  Yes 3.917 (2.584) 4.030 (2.607) 3.918 (2.392) 3.990 (2.224) 3.963 (2.455)
  P value 0.004 0.0002 0.054 0.007 <0.0001
Sports activity 
  At least one sport 3.762 (2.573) 3.690 (2.510) 3.671 (2.414) 3.771 (2.188) 3.722 (2.443)
  None 3.889 (2.562) 4.217 (2.651) 4.140 (2.343) 4.051 (2.237) 4.086 (2.432)
  P value 0.239 <0.0001 <0.0001 0.0057 <0.0001
Alcohol consumption 
  Non-drinker 4.310 (2.752) 4.794 (2.851) 4.331 (2.638) 3.984 (2.119) 4.338 (2.596)
  Social drinker 3.900 (2.533) 4.297 (2.679) 4.157 (2.379) 3.977 (2.250) 4.073 (2.477)
  Moderate drinker 3.668 (2.636) 3.518 (2.407) 3.783 (2.353) 3.864 (2.149) 3.694 (2.410)
  Daily drinker 3.687 (2.499) 3.480 (2.431) 3.496 (2.310) 3.707 (2.245) 3.580 (2.362)
  P value 0.006 <0.0001 <0.0001 0.068 <0.0001
Body mass index (kg/m2) 
  Under 18.5 2.200 (1.728) 2.214 (1.477) 2.692 (1.652) 3.714 (1.267) 2.543 (1.674)
  18.5 and below 25 2.636 (1.973) 2.446 (1.813) 2.643 (2.007) 2.799 (1.783) 2.619 (1.908)
  25 and below 30 3.737 (2.277) 3.587 (2.266) 3.589 (2.138) 3.818 (2.031) 3.680 (2.179)
  30 and below 40 5.633 (2.600) 5.173 (2.647) 4.971 (2.369) 4.641 (2.355) 5.072 (2.513)
  Above 40 6.912 (2.361) 6.505 (2.452) 5.818 (2.383) 5.773 (2.400) 6.301 (2.434)
  P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Results are presented for each gender and each class of the categorical covariates. Differences in BHS across covariate categories (1) within each age group and (2) across all age groups (last column) were investigated 
using a Kruskal-Wallis rank test and the corresponding p values are reported.
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Figure 1 BHS distributions by age groups and educational levels. For 
each category the point estimate of the mean BHS is represented by a 
bullet, and the vertical line represents the 2.5%–97.5% CI of the score 
in that category. Low, intermediate and high education are represented 
in red, green and blue, respectively, and results are presented for 
men (A) and women (B) separately. For both genders and within each 
age class, potential differences in mean BHS by SEP (Socio Economic 
Position) category are tested using a Student’s t-test, setting the mean 
BHS in the high education category as a reference. We report the 
corresponding p value above the boxplots for low and intermediate 
education groups. Trends across the three education categories for both 
genders and within each age class were tested for using a Kruskal-
Wallis test, and the corresponding p value is reported in the upper 
part of the plots. For readability, p values were coded as * for p values 
in (0.05, 0.01), ** for p values in (0.01, 0.001) and *** for p values 
<0.001. BHS, Biological Health Score.
showed that the differences we identified were consistent in the 
low-to-high education group comparisons.
The strongest differences were observed for the inflamma-
tory subscore, which showed (for all age groups in both men 
and women) higher mean values in participants with lower 
education. The metabolic subscore was also found to be statis-
tically higher in the low education group in women (for all age 
groups; table 2B) and in men (for all age groups except for the 
41–52 years group; table 2A). Differences in the mean metabolic 
subscore in the intermediate education group were weaker and 
less consistent across age groups.
Excluding from the BHS (1) one biological system at a time 
and (2) both liver and kidney functions, we found that both in 
men (figure 2A) and women (figure 2B), and across all four age 
groups, the exclusion of the inflammatory system attenuates the 
differences in the mean score especially in men aged 41–52 years 
and 53–64 years, where differences lose statistical significance 
(p>0.05). Conversely, the exclusion of the cardiovascular system 
seems to strengthen the differences in all age groups in men and 
women.
The relative contribution of each system to the BHS in men 
(figure 3A) and women (figure 3B) shows all system contributed 
to the BHS. However, their relative contribution varies across 
age groups in participants with lower education. These differen-
tial contributions are attenuated in the intermediate education 
group and almost non-existent in the higher education group.
The linear regression coefficients reported in table 3 repre-
sent the average adjusted contribution of education to the BHS. 
Results from the unadjusted model (model 1) suggest that BHS 
in the low and intermediate education groups are higher than in 
the high education group (p<0.05) in both men (table 3A) and 
women (table 3B) across all age groups, except for men in the 
low education group in the 20–40 years and 41–52 years age 
groups and in women with intermediate education group aged 
65–79 years old. Differences between low and high education 
groups (p<0.05) are mostly observed in men older than 53 years 
and in women from the first three age groups. In women from 
the 20–40 years and 53–64 years age groups and in men from the 
53–64 years age group, the average differences in BHS between 
low and high education groups are attenuated on adjustment 
for comorbidity, treatment, behaviours and BMI, but remained 
below 0.05 throughout the six different models. For the other 
age groups, the observed differences in BHS were attenuated 
(p>0.05) on adjustment for behaviours (model 6) in men and 
women (model 5). This suggests that the association between 
BHS values in low and high education groups cannot be fully 
explained by the covariates in these age groups.
We found differences (p<0.05) in mean BHS between inter-
mediate and high education groups, in both gender for all age 
groups, except for women aged 65–79 years. These differences 
appeared independent of all covariates considered in women 
from the 20–40 age group.
dIsCussIon
Main findings
In this study, we extended the concept of the AL in a multisystem 
BHS measuring features of the four physiological systems orig-
inally included in the AL (endocrine, inflammatory, cardiovas-
cular and metabolic systems) and the function of two key organs 
(liver and kidney). We found a persistent socioeconomic gradient 
in the BHS in men and women and across age groups, leading to 
the more socially disadvantaged being at greater biological risk. 
Because the score was calculated using the distribution of the 
biomarkers in each gender and age group separately (see box 1), 
our estimates of the BHS do not capture the natural age-related 
changes in the individual level of functioning. As such, the slight 
changes in BHS we observe across age groups cannot be inter-
preted as being related to the natural age-related variability of 
the BHS. We found that each system contributed to the BHS 
and its differential distribution by age, gender and SEP catego-
ries, but we identified that the inflammatory system and, to a 
lesser extent, the metabolic system consistently drove (across 
age groups and gender) the observed values of the BHS. Overall 
our analyses suggest that the effect of SEP is detected for most 
biological systems, independently of the SEP-related covariates 
and is generally more consistent in women.
SEP was associated with biological health risk from early 
adulthood, and this association was not explained by covari-
ates such as comorbidity or lifestyle in this sample of UK resi-
dents. These findings highlight evidence of social-to-biological 
processes leading to health inequalities from early adulthood.
Comparison with previous studies
Overall, our findings are consistent with work carried out in 
other dominantly white populations from high-income countries 
using the multibiomarker indicator AL. This confirms that this 
type of aggregate score, which summarises information across 
different biological systems, is able to capture a dimension of 
physiological health above and beyond individual biomarkers 
or systems.9 21 Our sensitivity analyses reinforce this message, 
showing that adding the extra systems (here limited to liver and 
kidney) to the AL indicator may pick up additional differences 
in physiological function or dysfunction leading to pathologies. 
As such our study warrants future and further extensions of the 
AL so that it includes additional systems that may contribute to 
social gradients in health.
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Figure 2 Sensitivity analysis investigating changes in p value induced 
by the exclusion of each system separately from the Biological Health 
Score (BHS). We report on the x axis the different scores considered (ie, 
removing one system at a time or both kidney and liver functions to 
mimic the allostatic load). The p value reported on the y axis measures, 
in each age group and gender, the significance of the difference 
between the mean score in the low (red) and intermediate (green) 
educational level group compared with the mean score in the reference 
group (higher education). As a reference, we report results from the 
full BHS (horizontal coloured dashed line). Results are presented for 
each age class separately in men (A) and women (B), and the black 
horizontal dotted lines represent the 0.05 significance level.
Figure 3 Relative contribution of each system-specific subscore 
to the Biological Health Score (BHS). Results are presented for men 
(A) and women (B) separately, and for each group of educational 
level: low (left), intermediate (middle) and high (right). To account for 
the differential number of biomarkers assayed in each system, the 
contribution is calculated based on a normalised system-specific score.
In order to ascertain possible modifications to the pattern of 
biological risk across age groups, we sequentially linked educa-
tion and BHS adjusting for possible confounders. In several 
models, the relationship between education and biological health 
was attenuated after adjusting for comorbidities, treatments and 
behaviours. These findings are consistent with the increase in 
comorbidities associated with lower SEP and increased age, and 
consequently in treatments for diseases or biomarkers that may 
contribute to our BHS. Our results are also consistent with the 
well-established association linking SEP and behaviours and 
obesity. BMI may thus appear as a particularly important medi-
ator of the association between education and biological func-
tioning/risk in this population. It is however noteworthy that the 
association between lower education and higher BHS remained 
statistically significant after adjustment for all covariates in some 
age groups (53–64 years in men, and 20–40 years and 53–64 
years in women), hence suggesting that other mechanisms are 
involved in the way education exerts its effect on biological func-
tioning and health.
strengths and weaknesses of the study
The large population size from a wide age range and the broad 
panel of biomarkers available, allowing us to adopt a systems 
approach, represent a key strength of this study. Most other 
studies focusing on biological wear-and-tear and biological 
health are in middle-aged or elderly participants, especially when 
multiple biomarkers are used. Here, we were able to examine 
whether socially patterned differences in biological health were 
observed in young adults. Nevertheless, to perform our analyses, 
and in line with previous investigations using Understanding 
Society, a large fraction (n=25 700 out of 35 875) of the study 
participants were excluded based on the availability of both (1) 
a blood sample and (2) a full nurse assessment. As a result, the 
included population is not representative of the general UK 
population anymore.15 Individual weights capturing differential 
response rates across population subgroups have been developed 
and could be applied to each observation in our study popu-
lation to ensure the applicability of our results to the general 
population. However, these would result in a substantial drop 
in the number of effective observations in the younger age 
groups, which represents a particularly important subpopulation 
in our study. For that reason, we decided to restrict our work 
to unweighted analyses and carefully interpreted our findings, 
avoiding any generalisation to the full UK population.
The main limitation of our work resides in its cross-sectional 
nature. By construction we cannot discern if the social differ-
ences in biological health observed in the younger age group 
persist across the life course, or whether these relationships are 
specific to the age, calendar time and demographic structure of 
this cross-sectional population. In particular, our study popula-
tion does not allow to quantify to which extent the age-related 
differences in BHS can be attributed to age itself or to calendar 
time differentials in the exposures and experiences captured by 
education. This calls for a cautious interpretation of our findings; 
to disentangle the age and calendar contribution to the effects 
we detect, analysis of longitudinal data is warranted. In addition, 
due to its cross-sectional nature, comorbidities reported in our 
study are prevalent. Therefore, our conclusion that the BHS may 
be able to capture existing pathological processes should not be 
misinterpreted in a causal or predictive context.
We used a straightforward method relying on dichotomising 
the level of each biomarker to calculate the BHS, which has 
been used to construct the AL score in previous works. The 
construction of such synthetic scores relying on the discretisa-
tion of the biomarkers level, and its present application defining 
the biomarkers quantiles for each gender and age group sepa-
rately, makes our inference robust to the way each system is 
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Table 3 Mean (and SE) contribution of education to the BHS by age group
(A) Men Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
 β (se) p value β (se) p value β (se) p value β (se) p value β (se) p value β (se) p value
20–40 years old (reference high SEP, n=381)
  Low (n=29) 0.84 (0.53)
1.09e-01
0.86 (0.52)
1.01e-01
0.76 (0.52)
1.40e-01
0.56 (0.52)
2.79e-01
0.59 (0.52)
2.63e-01
0.29 (0.46)
5.24e-01
  Intermediate (n=331) 0.4 (0.2)
5.12e-02
0.42 (0.2)
3.80e-02
0.43 (0.2)
3.52e-02
0.36 (0.2)
7.70e-02
0.36 (0.2)
8.06e-02
0.01 (0.18)
9.47e-01
41–52 years old (reference high SEP, n=339)
  Low (n=39) 0.42 (0.42)
3.17e-01
0.45 (0.43)
2.92e-01
0.4 (0.42)
3.40e-01
0.4 (0.42)
3.44e-01
0.09 (0.42)
8.39e-01
0.04 (0.39)
9.28e-01
  Intermediate (n=441) 0.43 (0.18)
1.70e-02
0.43 (0.18)
1.76e-02
0.44 (0.18)
1.39e-02
0.45 (0.18)
1.18e-02
0.37 (0.18)
4.14e-02
0.19 (0.17)
2.61e-01
53–64 years old (reference high SEP, n=330)
  Low (n=108) 0.86 (0.27)
1.30e-03
0.77 (0.27)
4.11e-03
0.69 (0.26)
8.97e-03
0.65 (0.26)
1.45e-02
0.67 (0.28)
1.51e-02
0.55 (0.26)
3.60e-02
  Intermediate (n=436) 0.39 (0.17)
2.68e-02
0.37 (0.17)
3.54e-02
0.32 (0.17)
6.58e-02
0.31 (0.17)
6.84e-02
0.3 (0.18)
8.53e-02
0.2 (0.17)
2.30e-01
65–79 years old (reference high SEP, n=277)
  Low (n=207) 0.58 (0.2)
4.51e-03
0.54 (0.2)
7.70e-03
0.51 (0.2)
1.21e-02
0.45 (0.2)
2.66e-02
0.33 (0.21)
1.11e-01
0.25 (0.2)
2.13e-01
  Intermediate (n=407) 0.44 (0.17)
1.12e-02
0.38 (0.17)
2.86e-02
0.35 (0.17)
4.34e-02
0.33 (0.17)
5.44e-02
0.26 (0.17)
1.35e-01
0.18 (0.16)
2.63e-01
(b) Women Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
β (se) p value β (se) p value β (se) p value β (se) p value β (se) p value β (se) p value
20–40 years old (reference high SEP, n=581)
  Low (n=28) 2.1 (0.47)
1.01e-05
2.07 (0.47)
1.45e-05
1.95 (0.46)
2.54e-05
1.73 (0.46)
1.61e-04
1.66 (0.46)
2.84e-04
1.02 (0.41)
1.22e-02
  Intermediate (n=445) 0.63 (0.15)
4.59e-05
0.63 (0.15)
5.46e-05
0.54 (0.15)
4.00e-04
0.56 (0.15)
1.90e-04
0.54 (0.15)
3.24e-04
0.33 (0.13)
1.53e-02
41–52 years old (reference high SEP, n=508)
  Low (n=68) 1.23 (0.34)
2.52e-04
1.21 (0.34)
3.23e-04
0.87 (0.32)
7.41e-03
0.74 (0.32)
2.14e-02
0.33 (0.33)
3.15e-01
0.2 (0.3)
5.01e-01
  Intermediate (n=622) 0.61 (0.16)
9.20e-05
0.59 (0.16)
1.66e-04
0.49 (0.15)
1.17e-03
0.48 (0.15)
1.19e-03
0.31 (0.15)
3.50e-02
0.19 (0.13)
1.50e-01
53–64 years old (reference high SEP, n=367)
  Low (n=213) 1.27 (0.2)
1.91e-10
1.24 (0.2)
6.67e-10
1.01 (0.2)
4.52e-07
0.95 (0.2)
2.08e-06
0.73 (0.2)
3.63e-04
0.58 (0.19)
2.57e-03
  Intermediate (n=520) 0.37 (0.16)
1.69e-02
0.38 (0.16)
1.66e-02
0.3 (0.15)
5.13e-02
0.3 (0.15)
5.53e-02
0.2 (0.16)
2.07e-01
0.09 (0.15)
5.42e-01
65–79 years old (reference high SEP, n=279)
  Low (n=294) 0.47 (0.19)
1.45e-02
0.45 (0.19)
2.11e-02
0.35 (0.19)
7.28e-02
0.32 (0.19)
1.01e-01
0.27 (0.2)
1.82e-01
0.17 (0.19)
3.76e-01
  Intermediate (n=409) −0.08 (0.18)
6.50e-01
−0.1 (0.18)
5.95e-01
−0.14 (0.18)
4.36e-01
−0.16 (0.18)
3.85e-01
−0.19 (0.18)
2.93e-01
−0.19 (0.17)
2.75e-01
Results are presented in men (A) and women (B) separately and effects are calculated for the unadjusted model (model 1) and for models sequentially adjusting for marital status and 
overcrowding (model 2), comorbidities (model 3), medical treatments (model 4), smoking, physical activity and alcohol (model 5), and BMI (model 6). These analyses are restricted to (n=3325 
men and n=4334 women) participants with full information on the confounders included in these six models. For each age group, the difference between the effect estimated in the low and 
intermediate SEP (Socio Economic Position) groups and that of the high SEP group was tested using a Student’s t-test, and differences with p values below the nominal 0.05 significance level 
are reported in bold.
BHS, Biological Health Score; BMI, body mass index.
measured. For instance, glomerular filtration rate (GFR) could 
be used instead of creatinine levels to measure kidney func-
tion. However, by construction the ranking of the participants 
(within each age group and sex), according to either the GFR 
and creatinine levels, will remain unchanged. Hence, the creat-
inine to GFR transformation would not have any impact on 
our subsequent inferences. Other methods can be employed 
to formulate a measure of biological health and have been 
used to examine the internal consistency and dimensionality of 
these types of multibiomarker scores.22 23 Overall this relatively 
simple approach, which uses the sample distribution of each 
biomarker to define the group most ‘at risk’, ultimately creating 
a single synthetic score, has been shown to successfully capture 
a common variance21 between AL components as hypothesised 
by the originators.1 9 This type of targeted approaches relying 
on established and functionally characterised biomarkers could 
be complemented by more agnostic investigations as exem-
plified by the recent development of biological clock using 
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high-throughput data, and in particular DNA methylation.24–26 
The clocks have been shown to be related to ageing, mortality, 
and more recently to be affected by social adversity.27 As such, 
one natural extension of our work would be to screen for molec-
ular signatures of our BHS extension of the AL and to evaluate 
how these are related to the CpG sites contributing to the estab-
lished methylation clocks.
ConClusIons And IMplICATIon For FuTure reseArCH
Our findings highlight that social-to-biological processes leading 
to health inequalities adversely affect biological health from early 
adulthood and independently from social-related exposures. We 
show that social differences in biological risk cannot be fully24–26 
explained by lifestyle or behavioural factors, which warrants 
further investigations to identify the additional ageing-relevant 
information that the kind of biological risk measure brings about.
Disadvantaged social conditions should be considered as a 
precursor to accelerated biological ageing from early adulthood 
and as serious targets for public health policies. Social-to-bio-
logical processes beginning in the childhood environment are 
likely to form a chain of events that lead to socially differen-
tiated biological states and health inequalities. Such processes 
could be at play in the recent shifts in life expectancy observed 
in high-income countries.28 Policy makers working on child care 
provision, housing and educational facilities must consider these 
areas as risk factors for social-to-biological processes involved in 
the construction of health inequalities.
What is already known on this subject
 ► It is established that social position impacts the quality 
of ageing, through the stimulation/dysregulation of key 
physiological systems during the life course.
 ► Composite scores as the allostatic load can be used to 
measure individual physiological wear-and-tear, and scores 
focusing on the physiological response to stress have shown 
social gradients in biological risk among the elderly.
What this study adds
 ► In the present study, as a potential extension of the allostatic 
load, we include two additional key systems and organs 
not primarily involved in the stress response, and analyse 
this extended score in a large age range from early to late 
adulthood.
 ► We show that education-related physiological differentials 
can already be detected in early adulthood (20–40 years age 
group) and that these are not solely driven by lifestyle and 
behavioural factors.
 ► We show that while both the inflammatory and metabolic 
systems have a consistent contribution to biological 
risk throughout the life course, other systems seem to 
differentially impact the Biological Health Score at different 
ages.
 ► Our findings suggest that the social-to-biological processes 
leading to health inequalities can be detected early in life 
and therefore highlight early adulthood disadvantaged social 
condition as a precursor to accelerated biological ageing.
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